Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Disease-modifying Therapy Discontinuation and Outcomes of Older People with Multiple Sclerosis (MS) at a Large Academic MS Center in Toronto, Canada

Author:Tsai, Chia-Chen   Raufdeen, Fasna   Schneider, Raphael   Marriott, James   Oh, Jiwon   

Session Name:S3: Multiple Sclerosis: Clinical Trials  

Topic:Multiple Sclerosis  

Program Number:S3.005  

Author Institution:University of British Columbia, Vancouver, BC, Canada  University of Toronto, Toronto, ON, Canada  

Tolebrutinib Versus Teriflunomide in Relapsing Multiple Sclerosis: Efficacy and Safety Results from the Phase 3 GEMINI 1 and 2 Trials

Author:Oh, Jiwon   Arnold, Douglas L.   Cree, Bruce A.C.   Ionete, Carolina   Kim, Ho Jin   Sormani, Maria Pia   Syed, Sana   Chen, Yixin   Maxwell, Christina R.   Benoit, Patrick   Turner, Timothy J.   Wallstroem, Erik   Wiendl, Heinz   

Session Name:PL5: Clinical Trials Plenary Session  

Topic:Multiple Sclerosis  

Program Number:PL5.008  

Author Institution:St. Michael’s Hospital, University of Toronto, Toronto, Canada, Toronto, ON, Canada  NeuroRx Research, Montréal, Canada, Montreal, QC, Canada  UCSF Weill Institute for Neurosciences, University of California San Francisco, Department of Neurology, San Francisco, United States, San Francisco, CA  UMass Chan Medical School, Worcester, United States, WORCESTER, MA  National Cancer Center, Department of Neurology, Goyang, South Korea, Goyang, Korea, Republic of  University of Genoa, Department of Health Sciences, Genoa, Italy, Genoa, Italy  Sanofi, Cambridge, United States, Cambridge, MA  Sanofi, Cambridge, United States, Mullica Hill, NJ  Sanofi, Chilly-Mazarin, France, Chilly Mazarin, France  Department of Neurology and Neurophysiology, University of Freiburg, Freiburg, Germany, Muenster, Germany  

Fenebrutinib Maintains Low Disease Activity in Relapsing Multiple Sclerosis: Results from the FENopta Trial Open-label Extension

Author:Oh, Jiwon   Drulovic, Jelena   Dufek, Michal   Budincevic, Hrvoje   Habek, Mario   Caunt, Maresa   Sierzega, Malgorzata   Clayton, David   Chen, Ying-Fang   Ratchford, Jack   Goodyear, Alexandra   Bar-Or, Amit   

Session Name:P8: Multiple Sclerosis: Disease-modifying Therapies: Real-world Evidence and Adverse Events 2  

Topic:Multiple Sclerosis  

Program Number:P8.005  

Author Institution:St. Anne's University Hospital Brno, Teplice, Czech Republic  Solmed Polyclinic and Sveti Duh University Hospital, Zagreb, Croatia  University Hospital Center Zagreb, Zagreb, Croatia  Genentech, Inc., South San Francisco, CA  F. Hoffmann-La Roche Ltd, Basel, Switzerland  University of Pennsylvania, Philadelphia, PA